For research use only. Not for human consumption.
ARA-290 (also known as Cibinetide or pHBSP) is an 11-amino-acid synthetic peptide derived from the tissue-protective helix B domain of erythropoietin (EPO).
$50.00
ARA-290 (also known as Cibinetide or pHBSP) is an 11-amino-acid synthetic peptide derived from the tissue-protective helix B domain of erythropoietin (EPO). Designed as a non-erythropoietic analog, it selectively binds and activates the Innate Repair Receptor (IRR)—a heteromer formed by the erythropoietin receptor and the beta-common receptor or CD131)—without stimulating red blood cell production.
Neuropathic Repair & Small Fiber Neuropathy: Studied for its ability to stimulate nerve fiber regeneration, reduce neuropathic pain signaling, and increase small nerve fiber density in peripheral tissues.
Anti-Inflammatory Cytokine Regulation: Evaluated for its capacity to downregulate pro-inflammatory cytokines via activation of the Innate Repair Receptor during tissue injury.
Tissue Protection & Ischemic Cytoprotection: Researched in metabolic and organ injury models for protecting vascular endothelium, suppressing apoptosis, and enhancing recovery after ischemic or diabetic stress.
To provide a selective Innate Repair Receptor agonist for investigating peripheral nerve regeneration, anti-inflammatory signaling cascades, cellular protection mechanisms, and neuropathic repair pathways in laboratory research.
| Property | Details | ||
| Product Name | ARA-290 (Cibinetide) | ||
| Product Category | Cytoprotective & Neuroregenerative Peptides | ||
| Compound Type | Synthetic 11-Amino-Acid EPO-Derived Peptide Fragment | ||
| Primary Goal | Innate Repair Receptor (IRR) activation, peripheral nerve repair, and inflammatory signaling mitigation research | ||
| Form | Lyophilized powder (vial) | ||
| Storage | Store lyophilized powder at 2°C to 8°C (refrigerated) or -20°C for long-term storage. | ||
| Protect from direct light. | |||
| Dosage | 12.5MG |
|---|
Explore similar research-grade peptides, selected to complement your research needs.
By proceeding you affirm the statements above are true. This site uses cookies to remember your verification status. Privacy Policy.
